You are here

  • Home
  • Archive
  • Volume 11, Issue 2
  • IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM

 

Online download statistics by month:

Online download statistics by month: February 2023 to February 2026

AbstractFullPdf
Feb 202310521070406
Mar 2023462470196
Apr 202324825197
May 202322222586
Jun 2023233239117
Jul 202323924197
Aug 202329229883
Sep 202319720084
Oct 2023212217104
Nov 202323123281
Dec 2023198207119
Jan 2024168170127
Feb 202414214494
Mar 2024245247155
Apr 2024232232137
May 202414614697
Jun 2024144144113
Jul 2024190193127
Aug 202413413488
Sep 2024160165584
Oct 2024185186119
Nov 2024228235146
Dec 2024189196132
Jan 2025202209110
Feb 2025269279143
Mar 2025226227160
Apr 2025239242146
May 2025214214125
Jun 202514114477
Jul 2025110
Sep 2025110
Feb 2026110
Total704371604150